💊 Arzneimittel A-Z 🧬 Targets 🛠 Werkzeuge 📚 Leitfäden
Alle Arzneimittel Arzneimittelklassen Therapeutische Bereiche Nebenwirkungen
Leitfäden Glossar Zeitleiste
Vergleiche Arzneimittelreisen Arzneimittel-Wirkstoffgruppen
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Iron Sucrose

CHEMBL1200823 Phase 4 Zugelassen Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

This intravenous iron preparation provides iron directly into the bloodstream for patients with iron deficiency anemia who cannot take or absorb oral iron, particularly those with chronic kidney disease. The sucrose carrier stabilizes the iron and helps reduce the risk of allergic reactions compared to some other injectable iron preparations. It is used to restore hemoglobin levels and iron stores.

Therapeutische Bereiche

Ovarian Cancer Inflammatory Bowel Disease Chronic Kidney Disease Lymphoma Hypertension Malaria Heart Failure Cardiovascular Disease Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This intravenous iron preparation provides iron directly into the bloodstream for patients with iron deficiency anemia who cannot take or absorb oral iron, particularly those with chronic kidney disease. The sucrose carrier stabilizes the iron and helps reduce the risk of allergic reactions compared to some other injectable iron preparations. It is used to restore hemoglobin levels and iron stores.

Yes, Iron Sucrose is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200823. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.